oxcarbazepine has been researched along with Developmental Disabilities in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Christensen, J; Daugaard, CA; Dreier, JW; Pedersen, L; Sun, Y | 1 |
| Baek, JH; Eun, BL; Kim, GH; Kim, MK; Seo, YH | 1 |
| Chillag, KL; Deroos, ST | 1 |
3 other study(ies) available for oxcarbazepine and Developmental Disabilities
| Article | Year |
|---|---|
Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Denmark; Developmental Disabilities; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant; Intellectual Disability; Lamotrigine; Male; Oxcarbazepine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Valproic Acid | 2020 |
Vitamin D levels in children and adolescents with antiepileptic drug treatment.
Topics: Adolescent; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Carbamazepine; Child; Child, Preschool; Developmental Disabilities; Epilepsy; Female; Humans; Intellectual Disability; Male; Osteoporosis; Oxcarbazepine; Retrospective Studies; Valproic Acid; Vitamin D; Vitamin D Deficiency | 2014 |
Oxcarbazepine use in paroxysmal kinesigenic dyskinesia: report on four patients.
Topics: Adolescent; Age of Onset; Anti-Dyskinesia Agents; Carbamazepine; Child; Developmental Disabilities; Dyskinesias; Emotions; Female; Humans; Male; Migraine with Aura; Neurologic Examination; Oxcarbazepine; Stereotyped Behavior | 2009 |